Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Xenon Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
XENE
Nasdaq
2836
www.xenon-pharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Xenon Pharmaceuticals Inc.
RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug
- Jul 2nd, 2025 1:20 am
Xenon Joins the Russell 3000® and Russell 2000® Indexes
- Jun 27th, 2025 2:01 pm
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jun 26th, 2025 2:01 pm
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
- Jun 24th, 2025 6:30 am
Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?
- Jun 11th, 2025 9:30 am
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
- Jun 3rd, 2025 2:01 pm
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
- May 14th, 2025 2:01 pm
Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday
- May 14th, 2025 6:18 am
Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus
- May 13th, 2025 10:07 am
Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ...
- May 13th, 2025 1:09 am
Xenon Pharmaceuticals: Q1 Earnings Snapshot
- May 12th, 2025 2:10 pm
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
- May 12th, 2025 2:01 pm
Xenon to Report Q1 2025 Financial Results on May 12, 2025
- May 5th, 2025 2:01 pm
Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?
- May 5th, 2025 7:55 am
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
- Apr 4th, 2025 6:30 am
Xenon to Present at Stifel 2025 Virtual CNS Forum
- Mar 12th, 2025 2:01 pm
Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus
- Feb 28th, 2025 7:36 am
Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...
- Feb 28th, 2025 12:36 am
Xenon Pharmaceuticals: Q4 Earnings Snapshot
- Feb 27th, 2025 2:18 pm
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
- Feb 27th, 2025 2:01 pm
Scroll